CAS No. : 996-31-6
(Synonyms: DL-Lactic acid (potassium); E-270 (potassium))
| Size | Price | Stock |
|---|---|---|
| 100g | $10 | In-stock |
| 500g | $30 | In-stock |
| 1000g | $53 | In-stock |
| > 2 kg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-B2227C |
| M.Wt: | 128.17 |
| Formula: | C3H5KO3 |
| Purity: | >98 % |
| Solubility: | H2O : 50 mg/mL (ultrasonic) |
Lactic acid (DL-Lactic acid) potassium is a hydroxycarboxylic acid receptor 1 (HCAR1) activator and an epigenetic modulator inducing lysine residues lactylation. Lactic acid potassium is a glycolysis end-product, bridging the gap between glycolysis and oxidative phosphorylation. Lactic acid potassium is an oncometabolite and has immune protective role of lactate in anti-tumor immunity[1][2]. Lactic acid also potassium has antimicrobial activity, which can be used as a food preservative[3].
IC50 & Target:Bacterial[2]
In Vitro:Lactic acid (20 mM; 24, 48 h) potassium results in a significant decrease in cell proliferation and migration, acting and switching cell metabolism toward oxidative phosphorylation[1].
Lactic acid (20 mM; 24 h) potassium shows an increase in the protein and mRNA expression levels of MCT1 and HCAR1[1].
In Vivo:Lactic acid (1.6 g/kg; pH 7.4; subcutaneous; daily from Day 8 to 30 days) potassium shows CD8+ T cell-dependent tumor growth inhibition in MC38 colon cancer model[2].
Note: The pH of the working solution needs to be adjusted to around 7.4 before administration to animals.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.